Tag: immunohistochemistry IHC market size

  • Immunohistochemistry IHC Market Growth Potential: Key Insights for 2024-2033

    Immunohistochemistry IHC Market Growth Potential: Key Insights for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Will the Immunohistochemistry IHC Market Grow from 2024 to 2033?

    The market size for immunohistochemistry (ihc) has experienced significant growth in recent times. It is forecasted to expand from $2.43 billion in 2023 to $2.65 billion in 2024, illustrating a compound annual growth rate (CAGR) of 8.8%. The reasons for this growth in the historic period may include the adoption of this method in clinics, the standardization of the industry, the broadening exploration in cancer research, the automation influx in laboratories, and advancements made in clinical diagnostics.

    The market size of immunohistochemistry (IHC) is projected to experience robust growth in the coming years, reaching a value of $3.77 billion in 2028, with a compound annual growth rate (CAGR) of 9.3%. The anticipated surge in the forecast period could be ascribed to the participation of new entrants in the market, the substantial demand in drug development, incorporation of biomedical research, diagnostic purposes, automation, and digitalization. Expected major trends during this period comprise multiplex IHC techniques, integration into digital pathology, improved antibody specificity, automation & standardization, and its application in the detection of biomarkers.

    Claim Your Free Sample of the Global Immunohistochemistry IHC Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

    What Aspects Are Influencing the Growth Rate of the immunohistochemistry ihc Market?

    The immunohistochemistry (IHC) market is set to benefit from a projected rise in chronic diseases. Chronic diseases, defined as clinical conditions persisting for three months or longer, are typically manageable but incurable. IHC is invaluable for diagnosing these chronic conditions, namely cancer, cardiovascular diseases, and similar illnesses. This is due to its distinct advantages, which include specificity, sensitivity (allowing the detection of specific antigens), and the swift provision of results. In 2022, data from the Centers for Disease Control and Prevention, a national public health agency in the US, revealed that about 37.3 million individuals, making up 11.3% of the country’s population, are living with diabetes. Consequently, the escalating occurrence of chronic diseases is fueling the growth of the immunohistochemistry (IHC) market.

    What Are the Critical Segments of the Immunohistochemistry IHC Market?

    1) By Product: Antibodies, Equipment, Reagents, Kits

    2) By Applications: Diagnostics, Drug Testing, Other Applications

    3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

    What Trends Are Redefining Consumer Expectations in the Immunohistochemistry IHC Market?

    The immunohistochemistry (IHC) market is primarily driven by technological innovations. To establish a strong market position, leading companies are focusing on developing technologically superior products. An example of this is Akoya Biosciences, Inc, a US establishment that specializes in holistic solutions for high-parameter tissue analysis. In April 2021, they launched their new line of detection kits that utilize Opal multiplex technology, dubbed Akoya’s Opal Multiplex Detection Kits. This distinctive technique allows detection of multiple biomarkers within a single tissue section, using iterative single staining and the removal of the main stain through heat. Advantages of Akoya’s Opal Multiplex Detection Kits include phenotypic scoring through signal amplification, minimized sample and reagent use, the capacity to detect 3 to 8 IHC targets and nuclear stains, and a variety of other advanced functionalities.

    Order Now for Fast Delivery of Your Immunohistochemistry IHC Market Report!

    https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

    What Are the Leading Regions in the Immunohistochemistry IHC Market Expansion?

    North America was the largest region in the immunohistochemistry (IHC) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Immunohistochemistry IHC Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the immunohistochemistry ihc market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Immunohistochemistry IHC Market Include

    1. Immunohistochemistry IHC Market Executive Summary

    2. Immunohistochemistry IHC Market Segments

    3. Immunohistochemistry IHC Market Size And Template Market Growth Rate

    4. Key Immunohistochemistry IHC Market Trends

    5. Major Immunohistochemistry IHC Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Immunohistochemistry IHC Market

    26. Top Immunohistochemistry IHC Companies

    27. Immunohistochemistry IHC Market Opportunities And Strategies

    28. Immunohistochemistry IHC Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Growth Forecast For The Immunohistochemistry (IHC) Global Market 2024-2033

    Future Growth Forecast For The Immunohistochemistry (IHC) Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

     

    Introduction: Remarkable Growth Trajectory

    • Strong recent growth: $2.43 billion (2023) to $2.65 billion (2024) at 8.8% CAGR
    • Historic drivers: Clinical adoption, standardization, cancer research expansion, laboratory automation

    Anticipated Surge and Key Drivers

    • Expected growth: $3.77 billion (2028) at 9.3% CAGR
    • Contributing factors:
      • Market entry of new players
      • Demand in drug development
      • Biomedical research integration
      • Diagnostic applications
      • Automation and digitalization

    Personalized Medicine Catalysts Market Expansion

    • Growing demand for personalized medicines
    • Role of IHC in personalized medicine
    • Impactful statistics from the Personalized Medicine Coalition (PMC)

    Market Players and Innovations

    • Major companies driving market growth
    • Example: Akoya Biosciences’ Opal Multiplex Detection Kits
    • Focus on technological advancements

    View More On The Immunohistochemistry (IHC) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

    Strategic Acquisition Fuels Market Growth

    • StageBio’s acquisition of TPL Path Labs
    • Expansion of IHC portfolio
    • Market advantage through strengthened product offerings

    Market Segmentation Insights

    • By Product: Antibodies, Equipment, Reagents, Kits
    • By Applications: Diagnostics, Drug Testing, Other Applications
    • By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

    Regional Dynamics: North America and Asia-Pacific

    • North America’s dominance in 2023
    • Asia-Pacific’s forecasted rapid growth

    Conclusion: Charting the Future of IHC Market

    The immunohistochemistry (IHC) market emerges as a pivotal force in modern healthcare, fueled by innovation, research, and the demand for personalized treatment approaches. With robust growth projections and key drivers shaping its trajectory, the IHC market stands poised for transformative advancements. From personalized medicine to technological innovations, the market continues to evolve, offering new opportunities for players across the healthcare spectrum. Through strategic acquisitions, technological innovations, and a steadfast commitment to excellence, companies in the IHC market are driving positive outcomes and shaping the future of healthcare. As the market expands, fueled by innovation and market dynamics, it paves the way for a future where precision medicine and advanced diagnostics become the cornerstone of patient care. In a landscape defined by innovation and collaboration, the immunohistochemistry market pioneers new frontiers, offering hope, healing, and progress in the realm of healthcare.

    Request A Sample Of The Global Immunohistochemistry (IHC) Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9267&type=smp